Found 7 matching trials
TheraSphere With Durvalumab and Tremelimumab for HCC PHASE2 The objective of the ROWAN clinical study is to assess the efficacy of loca...
Show More Status
Active Not Recruiting
Location
University of California San Diego
Learn More & Join Trial
MANDARIN (S6371) PHASE3 To evaluate the efficacy and safety of TheraSphereTM yttrium \[90Y\] glass ...
Show More Location
Zhongda Hospital Southeast University
Learn More & Join Trial
RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry N/A This study is a non-interventional, observational, prospective, and global ...
Show More Learn More & Join Trial
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE PHASE2 The purpose of this study is to measure the efficacy and safety of durvalum...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma PHASE2 The purpose of this study is to determine the effects that Regorafenib in c...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma PHASE2 The purpose of this study is to determine the effects (good and bad) that T...
Show More Location
University of Miami
Learn More & Join Trial
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM PHASE1 The FRONTIER Study is a prospective, interventional, single-arm, multi-cent...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial